“High Cost Drugs”

22 result(s)
Cost Management
CVS Health is launching real-time benefits which, for the first time ever, will offer members and their health care providers transparent, real-time access to member-specific... More
Briefing
Pharmacist filling prescriptions in a timely manner
Cost Management
Paying-for-performance is where health care is headed. CVS Health’s new performance network will deliver unit cost savings, as well as improved clinical outcomes to help lower... More
Briefing
The MS Care Challenge
Cost Management
MS is a chronic, progressive and unpredictable condition and each patient’s needs are unique. Caring for MS patients requires a holistic, tailored approach. More
Briefing
Expensive Pill
Cost Management
Value-based management can only deliver on their promise of incremental cost-savings if the right guardrails are in place to ensure appropriate utilization and management. More
Briefing
24% Drop in Client Cost for Epinephrine Injectors
Cost Management
Despite triple digit price hikes, PBM trend management solutions helped lower the costs of epinephrine injectors 24% for clients for drugs covered under our Standard Control... More
Commentary
2018 Formulary Strategy Article
Cost Management
Formulary management is foundational in helping clients control costs. Value-based management strategies build upon the early success of formulary strategy for more targeted,... More
Commentary
Paying for Drugs Based on Outcomes
Cost Management
Value-based management seeks go beyond a static, pre-set price tag to uncover true value for drugs and better health for patients. More
Briefing
Specialty
Blockbuster cancer drug Zytiga may become first-line treatment for patients with metastatic, castration-resistant cancer, greatly expanding its market and cost impact. More
Feature
Aligning Drug Prices with Value
Cost Management
The current model of static, manufacturer-set drug prices is simply unsustainable. Value-based management approaches attempt to incentivize quality and efficacy. More
Briefing
Cost Management
New utilization management criteria ensure appropriate use of PCSK9 inhibitors, which can help lower bad cholesterol levels, but are significantly more expensive first-line... More
Briefing